Tavocept

Related by string. * * *

Related by context. All words. (Click for frequent words.) 73 Prestara 73 Amrubicin 70 BioNumerik 70 PROMACTA 69 Insegia 69 Velcade bortezomib 69 Neulasta ® 69 AEG# 69 Fibrillex TM 69 YONDELIS 69 vidofludimus 69 INTEGRILIN 68 CTAP# Capsules 68 sunitinib malate 68 BAY #-# 68 OPAXIO 68 darapladib 68 efalizumab 68 MAGE A3 ASCI 68 Panitumumab 68 IV Busulfex 68 Azilect ® 68 interferon gamma 1b 68 goserelin 68 EOquin TM 68 Symadex 68 PEG INTRON 68 Pirfenidone 68 oral FTY# 67 Granulocyte Colony Stimulating Factor 67 Tamibarotene 67 cinacalcet 67 Azedra 67 recurrent glioblastoma multiforme 67 elotuzumab 67 Traficet EN 67 Nexavar sorafenib 67 CIMZIA ™ 67 HuLuc# 67 ACTEMRA TM 67 valopicitabine 67 Proxinium TM 67 CoFactor 67 Hepatocellular Carcinoma HCC 67 Allovectin 7 67 recurrent NSCLC 67 Asentar 67 mertansine 67 custirsen 67 relapsed ovarian cancer 67 CBLC# 67 Virulizin R 67 Irinotecan 67 tocilizumab 67 Kepivance 67 adjuvant colon cancer 67 Cellegesic 67 terlipressin 67 radiation sensitizer 67 mycophenolate mofetil 67 talabostat 67 Bezielle 67 secondary hyperparathyroidism 67 pegylated liposomal doxorubicin 67 Arixtra 67 TRISENOX 67 Adhibit 67 Allovectin 7 R 67 ximelagatran 67 Targretin 67 phase IIb clinical 67 IRESSA 67 lomitapide 67 RhuDex ® 67 forodesine 67 FROVA 67 CR# vcMMAE 66 TAXOTERE ® 66 regorafenib 66 apaziquone 66 zanolimumab 66 EFAPROXYN 66 phase IIb trial 66 ARIMIDEX 66 oxymorphone ER 66 alvimopan 66 cinacalcet HCl 66 HuMax CD4 66 relapsing remitting MS RRMS 66 oxaliplatin Eloxatin 66 TELCYTA 66 tesmilifene 66 Dacogen decitabine 66 TroVax ® 66 sipuleucel T 66 Degarelix 66 SUPPRELIN R LA 66 pertuzumab 66 FOLOTYN ® 66 ospemifene 66 INCB# [003] 66 ONTAK 66 AQ4N 66 skeletal metastases 66 TORISEL 66 dacetuzumab 66 cilengitide 66 Civacir 66 evaluating tivozanib 66 rhThrombin 66 STRIDE PD 66 TEMODAL 66 Laquinimod 66 erlotinib Tarceva 66 Leukine 66 volociximab 66 glufosfamide 66 Ixempra 66 axitinib 66 oral ridaforolimus 66 Dasatinib 66 Zirgan 66 clodronate 66 TREANDA 66 zoledronic acid Zometa 66 decitabine 66 HuMax CD# 66 EndoTAG TM -1 66 ganetespib 66 bicalutamide 66 Canvaxin 66 HuMax EGFr 66 Noxafil 66 adecatumumab 66 Amplimexon 66 Fludara ® 66 Fludara 66 danoprevir 66 metastatic RCC 66 Gleevec imatinib mesylate 66 ELACYT 66 Revlimid lenalidomide 66 idraparinux 66 OvaRex ® MAb 66 Troxatyl 66 dirucotide 66 CIPN 66 reslizumab 66 ibandronate 66 H. pylori eradication 66 cediranib 66 TELINTRA 66 Vidaza azacitidine 65 infusional 5-FU/LV 65 atacicept 65 Genasense ® 65 bendamustine 65 OHR/AVR# 65 SNT MC# 65 faropenem 65 vandetanib 65 NOXAFIL 65 PD LID 65 ruxolitinib 65 invasive candidiasis 65 posaconazole 65 brivaracetam 65 Phase IIIb clinical 65 Alemtuzumab 65 Mipomersen 65 Raptiva ® 65 Raptiva R 65 iniparib 65 Virulizin ® 65 Cimzia TM 65 vorinostat 65 Evoltra 65 alvespimycin 65 metastatic renal cell carcinoma 65 bazedoxifene 65 octreotide implant 65 FASLODEX 65 angiogenesis inhibitor 65 VIDAZA 65 entinostat 65 rasagiline tablets 65 oral deforolimus 65 Folotyn 65 docetaxel Taxotere R 65 Campath ® 65 mRCC 65 Panzem R NCD 65 FACTIVE tablets 65 TYZEKA 65 Torisel 65 L BLP# 65 DU #b 65 enzastaurin 65 tecarfarin 65 eniluracil 65 Ophena 65 panitumumab 65 pain palliation 65 sorafenib Nexavar 65 Allovectin 7 ® 65 mapatumumab 65 recurrent GBM 65 antiplatelet agent 65 comparator arm 65 liver metastases 65 Defibrotide 65 sargramostim 65 talactoferrin 65 Mepact 65 Cetrorelix 65 lumiliximab 65 PRT# 65 temsirolimus 65 OZURDEX ® 65 Ceflatonin 65 pegylated interferons 65 ZOLINZA 65 romiplostim 65 Æterna Zentaris 65 Loramyc 65 Roche Xeloda 65 Panzem 65 PROCHYMAL 65 Mimpara 65 Tarceva TM 65 methylnaltrexone 65 canakinumab 65 FOLOTYN 65 PROCHIEVE 8 65 MyVax R 65 tramiprosate ALZHEMED TM 65 Sym# 65 huC# DM4 65 venous thromboembolic events 65 Microplasmin 65 ThermoDox R 65 Thalomid ® 65 Stimuvax 65 Advagraf 65 Vectibix 65 LY# [003] 65 Xanafide 65 ASA# 65 Betaferon ® 65 ELND# 65 Gliadel Wafer 65 octreotide LAR 65 Mycamine 65 ularitide 65 Mitoxantrone 65 lapatinib Tykerb 65 ceftaroline 65 Cethrin 65 Xelox 65 Vectibix panitumumab 65 otelixizumab 65 relapsed multiple myeloma 65 BRAF inhibitor 65 sorafenib tablets 65 PREOS 65 R sorafenib tablets 64 Zerenex 64 Aplidin 64 metastatic GIST 64 RSR# 64 tanespimycin 64 baminercept 64 ImClone Erbitux 64 oral salmon calcitonin 64 CYPHER Stent 64 Novartis Zometa 64 Lubiprostone 64 taribavirin 64 cetuximab Erbitux 64 teriflunomide 64 standard chemotherapy regimen 64 INCB# [001] 64 panitumumab Vectibix 64 fenretinide 64 YERVOY 64 APTIVUS 64 Diabetic Macular Edema 64 Omigard 64 Vandetanib 64 bardoxolone 64 AA Amyloidosis 64 Xinlay 64 MOZOBIL 64 PhosLo 64 NEUPOGEN 64 tolvaptan 64 XGEVA 64 rilonacept 64 Combidex 64 phase IIa clinical 64 Sebivo 64 CA4P 64 ATACAND 64 Plicera 64 Halaven 64 dexanabinol 64 PSMA ADC 64 palifermin 64 riociguat 64 Phenoptin 64 Natalizumab 64 Mycograb 64 Vicinium TM 64 #D#C# 64 paclitaxel eluting stents 64 motesanib 64 thetreatment 64 SERMs 64 ZADAXIN ® 64 KIACTA ™ 64 Increlex R 64 THALOMID 64 Viramidine 64 TAXUS Stent 64 acyclovir Lauriad R 64 Hycamtin 64 Zavesca ® 64 KRAS mutations occur 64 DIFICID 64 zalutumumab 64 Increlex TM 64 trabectedin 64 IL# PE#QQR 64 Pazopanib 64 MGd 64 alemtuzumab treated 64 RoACTEMRA 64 VELCADE melphalan 64 post menopausal osteoporosis 64 Ethyol 64 bevacizumab Avastin ® 64 HGS ETR2 64 Jevtana 64 Octreotide 64 CIMZIA TM 64 metastatic bladder 64 thalidomide Thalomid 64 Certican 64 IMA# 64 Ventavis 64 ixabepilone 64 ZACTIMA 64 OMNARIS Nasal Spray 64 chemotherapy induced neutropenia 64 dexpramipexole 64 CINTREDEKIN BESUDOTOX 64 Sanofi Aventis Taxotere 64 hyperphenylalaninemia HPA due 64 ARCOXIA 64 eltrombopag 64 SinuNase 64 AGILECT R 64 heterozygous FH 64 metastatic castration resistant 64 Catena ® 64 lupus nephritis 64 PSN# [002] 64 refractory angina 64 adalimumab Humira 64 liposomal doxorubicin 64 budesonide foam 64 bevacizumab Avastin 64 menadione 64 micafungin 64 SUTENT 64 NATRECOR R 64 Hematologic 64 ACZ# 64 placebo controlled clinical 64 Taxotere ® 64 cilostazol 64 AMEVIVE 64 Peginterferon alfa 2b 64 metastatic CRC 64 Azixa 64 G#DT 64 SomatoKine 64 Thal Dex 64 Nexavar ® 64 metastatic HRPC 64 Relivar 64 Daclizumab 64 Tacrolimus 64 olaparib 64 AEGR 64 castrate resistant prostate cancer 64 plasma kallikrein inhibitor 64 Nuvion 64 oral prodrug 64 Cytoxan 64 eculizumab 64 Evoltra ® 64 Factor VIIa 64 EXJADE 64 CD3 monoclonal antibody 64 refractory gout 64 pegfilgrastim 64 palonosetron 64 BRIM2 64 LymphoStat B 64 omega interferon 64 Somatuline Depot 64 receptor tyrosine kinase inhibitor 64 NEVO ™ 64 randomized Phase IIb 64 glatiramer acetate 64 Betaseron ® 63 levosimendan 63 CONBRIZA 63 Neulasta R 63 Telbivudine 63 Octreolin 63 pradefovir 63 aflibercept 63 MYDICAR ® 63 chemopreventive agent 63 gefitinib 63 recurrent GBM patients 63 acetonide FA 63 TroVax 63 FAMPYRA 63 ORENCIA R 63 AVASTIN 63 Phase Ib clinical 63 Filgrastim 63 Onco TCS 63 ATL# [001] 63 ocrelizumab 63 CDP# 63 Itopride 63 dacarbazine 63 CYT# potent vascular disrupting 63 Herceptin trastuzumab 63 subcutaneous formulation 63 depsipeptide 63 COPAXONE ® 63 lasofoxifene 63 proteasome inhibitor 63 fidaxomicin 63 letrozole Femara 63 amifostine 63 ProSavin 63 ridaforolimus 63 LIVALO 63 oropharyngeal candidiasis 63 REPLAGAL 63 Apaziquone 63 CMV disease 63 relapsing remitting multiple sclerosis 63 low dose cytarabine 63 Aflibercept 63 Macroplastique 63 anastrozole 63 rituximab Rituxan 63 adult chronic ITP 63 LUCENTIS 63 AZILECT ® 63 TYKERB 63 recurrent metastatic 63 TACI Ig 63 Ceflatonin R 63 NV1FGF 63 Actemra tocilizumab 63 investigational monoclonal antibody 63 HIF PHI 63 AzaSite Plus 63 Taxotere docetaxel 63 Bicifadine 63 NATRECOR ® 63 APOPTONE 63 refractory metastatic colorectal cancer 63 COPAXONE R 63 afatinib 63 romidepsin 63 samalizumab 63 gastrointestinal stromal tumors GIST 63 Actimmune ® 63 anidulafungin 63 figitumumab 63 PegIntron 63 UPLYSO 63 Myocet 63 Phase #b/#a clinical 63 Egrifta 63 amrubicin 63 pitavastatin 63 muraglitazar 63 CIMZIA TM certolizumab pegol 63 tipranavir 63 raloxifene Evista 63 Archexin 63 IMiDs 63 p# biomarker 63 oral fludarabine 63 azacitidine 63 registrational trial 63 mTOR inhibitors 63 insulin sensitizing 63 nitazoxanide 63 bendamustine HCl 63 ozarelix 63 TG# [003] 63 tenofovir emtricitabine 63 EVIZON 63 diabetic neuropathic pain 63 PAOD 63 ARIXTRA 63 UVIDEM 63 atherothrombotic events 63 cabazitaxel 63 zoledronic acid 63 PROSTVAC ® 63 AGILECT ® 63 synthetic retinoid 63 IRX 2 63 lucinactant 63 bortezomib Velcade 63 VANTAS R 63 Gemzar ® 63 Mylotarg 63 Ocrelizumab 63 docetaxel Taxotere ® 63 biliary tract cancer 63 Bendamustine 63 Emselex 63 novel VDA molecule 63 telaprevir VX 63 CAPHOSOL 63 relapsed MM 63 vismodegib 63 Increlex ® 63 RSD# oral 63 dose cohort 63 CytoFab 63 tafamidis 63 Vimpat R 63 YONDELIS R 63 Zavesca R 63 SIR Spheres 63 VALSTAR 63 DepoBupivacaine TM 63 Tesmilifene 63 mitoxantrone 63 Oracea ® 63 erlotinib Tarceva ® 63 CAELYX 63 SCCHN 63 rindopepimut 63 L MTP PE 63 interferon beta 1b 63 Neurodex 63 Targretin capsules 63 Soliris TM eculizumab 63 bone metastasis 63 RIGScan CR 63 anti angiogenic therapies 63 GW# [003] 63 Cleviprex TM clevidipine 63 Aryplase 63 Auxilium Pharma 63 CCR9 antagonist 63 Frova R 63 dirucotide MBP# 63 strontium ranelate 63 cobiprostone 63 VALSTAR TM 63 renal toxicity 63 PDE4 inhibitor 63 Phase Ib II 63 Solasia 63 eprotirome 63 Cinquil 63 Xeloda ® 63 metastatic colorectal 63 Argatroban 63 Integrilin 63 LAF# 63 Phase IIb trials 63 DFMO 63 FOLFOX6 63 Xerecept 63 Gemzar 63 bone metastases 63 SEBIVO 63 MabCampath 63 TRISENOX ® 63 Navelbine ® 63 teduglutide 63 PrevOnco 63 HER2 positive metastatic breast 63 6R BH4 63 Amigal 63 Losartan 63 miconazole Lauriad ® 63 ThermoDox ® 63 CANCIDAS 63 hepatocellular cancer 63 opioid induced bowel dysfunction 63 Aviptadil 63 PANVAC VF 63 MYLOTARG 63 PXD# 63 Candesartan 63 hypervascular tumors 63 capecitabine Xeloda 63 Evicel 63 arterial thrombosis 63 anakinra 63 vinorelbine 63 nucleotide analog 63 HGS ETR1 63 corticosteroid dexamethasone 63 Zenapax 63 Tarceva erlotinib 63 differentiated thyroid 63 Loramyc R 63 Femara letrozole 63 platelet inhibitor 63 VAPRISOL 63 bicifadine 63 SPRYCEL ® 63 androgen deprivation 63 Everolimus 63 Ambrisentan 63 Dextofisopam 62 Vitaxin 62 Junovan 62 Proleukin 62 anticancer therapy 62 oral mTOR inhibitor 62 Onconase 62 sitaxsentan 62 REBETOL combination therapy 62 Pemetrexed 62 Tolvaptan 62 febuxostat 62 Glufosfamide 62 Angiox 62 maribavir 62 GnRH agonists 62 velafermin 62 MEVACOR 62 JAK inhibitor 62 BCIRG 62 trastuzumab DM1 62 rilpivirine 62 antifibrinolytic 62 Bortezomib 62 ToGA 62 Zemplar Capsules 62 complete cytogenetic response 62 rNAPc2 62 recurrent ovarian cancer 62 ancrod 62 aerosolized AAT 62 REMICADE ® 62 Tyrima 62 APTIVUS r 62 BARACLUDE R 62 ACTEMRA 62 concurrent chemoradiation 62 thromboembolic disease 62 GAMMAGARD 62 Capesaris 62 ganaxolone 62 eritoran 62 Temsirolimus 62 Reclast Aclasta 62 Stimuvax R 62 gemcitabine chemotherapy 62 LymphoStat B belimumab 62 AmBisome 62 LEP ETU 62 amifampridine phosphate 62 XYOTAX 62 Diamyd ® 62 PNH patients 62 flutamide 62 non metastatic osteosarcoma 62 PTK ZK 62 Gleevec imatinib 62 Pivotal Clinical Trial 62 Clolar ® 62 benign prostatic hypertrophy BPH 62 HepaSphere 62 chemoradiotherapy 62 Dacogen injection 62 MabThera Rituxan 62 Atrasentan 62 AZOR 62 Theratope 62 sirolimus 62 Desmoteplase 62 R0 resection 62 picoplatin 62 motavizumab 62 mCRC patients 62 methylnaltrexone bromide 62 docetaxel chemotherapy 62 DAPT 62 IV bisphosphonates 62 DPP4 62 Arranon 62 Reverset 62 recurrent glioblastoma 62 Camptosar ® 62 immunomodulatory therapy 62 Telcyta 62 oral anticoagulant 62 bardoxolone methyl 62 cetuximab Erbitux R 62 Saforis 62 voclosporin 62 MYDICAR 62 XmAb# 62 elacytarabine 62 Vernakalant 62 tramiprosate Alzhemed TM 62 nonsmall cell lung cancer 62 Orazol 62 oral leukoplakia 62 TheraCIM 62 antibody MAb 62 induced macular edema 62 ARCALYST ® 62 Phase IIa trial 62 Tarvacin 62 tremelimumab 62 Ophena TM 62 locoregional recurrence 62 CYCLOSET 62 GED aPC 62 ponatinib 62 Cloretazine 62 ABILIFY ® 62 RLY# 62 dasatinib 62 investigational humanized monoclonal antibody 62 BCR ABL inhibitor 62 SNT-MC#/idebenone 62 Alzhemed TM 62 chronic idiopathic thrombocytopenic purpura 62 #I TM# 62 ARIKACE 62 Taxotere chemotherapy 62 IFN beta 62 assessing T DM1 62 K ras mutations 62 RAPTIVA R 62 metastatic neuroendocrine tumors 62 daclizumab 62 Vantas 62 tramiprosate 62 Alocrest 62 Proquin XR 62 advanced adenomas 62 MAXY G# 62 PEG SN# 62 endometrial hyperplasia 62 TREDAPTIVE 62 Acapodene 62 Treanda 62 Golimumab 62 Safinamide 62 GRNVAC1 62 HBeAg seroconversion 62 Evoltra TM 62 Abbokinase 62 gastrointestinal stromal tumors 62 Mitomycin C 62 oral rivaroxaban 62 cisplatin vinorelbine 62 Bevacizumab 62 Ozarelix 62 NeoVisc 62 ADVEXIN 62 Erbitux cetuximab 62 idiopathic pulmonary fibrosis IPF 62 pamidronate 62 Phase Ib IIa 62 Friedreich Ataxia FRDA 62 Frova ® 62 silodosin 62 systemic immunosuppressive drugs 62 Arimidex anastrozole 62 Protelos 62 neoadjuvant therapy 62 zileuton 62 pediatric malignancies 62 lenalidomide dexamethasone 62 Gleevec resistant 62 Eltrombopag 62 KRN# 62 atrasentan 62 RRMS patients 62 gefitinib Iressa 62 cannabinor 62 Increlex 62 PREZISTA r 62 DYNEPO 62 Cx# [002] 62 oral antidiabetic 62 Pertuzumab 62 Triolex 62 TH# [003] 62 ulimorelin 62 nucleoside analogs 62 Achieves Primary Endpoint 62 ERBITUX 62 Rectogesic 62 GRN# 62 Somatuline ® Depot 62 EGFR TKI 62 Fodosine 62 Procoralan 62 Roche Actemra 62 allogeneic stem cell 62 HoFH 62 Azilect R 62 laquinimod 62 estramustine 62 HGS# 62 EGFR expressing mCRC 62 HspE7 62 COMFORT II 62 Fulvestrant 62 noninfectious uveitis 62 anti EGFR antibody 62 calcineurin inhibitors 62 deforolimus 62 systemic fungal infections 62 Zometa zoledronic acid 62 BCR ABL inhibitors 62 pomalidomide 62 dasatinib Sprycel 62 refractory APL 62 Vidofludimus 62 Numax 62 calcitonin 62 Dapagliflozin 62 cintredekin besudotox 62 Plasmin 62 abiraterone acetate 62 belinostat 62 Starlix 62 Debio 62 schizophrenia CIAS 62 Arcalyst 62 ATL# [002] 62 reduce serum phosphate 62 RECOTHROM R 62 Tekamlo 62 DDP# 62 recurrent VTE 62 intravenous bisphosphonates 62 interferon beta therapy 62 anti angiogenic agents 62 AZILECT R 62 INSPIRE Trial Phase III 62 morphometric vertebral fractures 62 5-FU/LV 62 albinterferon alfa 2b 62 Personalized Immunotherapy 62 angiographic outcomes 62 taxane chemotherapy 62 esophageal candidiasis 62 Serdolect ® 62 Durezol 62 non squamous NSCLC 62 DPP4 inhibitor 62 elvucitabine 62 Factor Xa inhibitor 62 SUTENT ® 62 XYOTAX TM 62 NEBIDO 62 aleglitazar 62 gemcitabine Gemzar 62 EGFR tyrosine kinase inhibitors 62 DexaSite 62 Camptosar 62 AVONEX ® 62 Eraxis 62 Rilonacept 62 nucleoside analog 62 pseudobulbar affect PBA 62 metastatic renal cell 62 NAVISTAR R 62 Xenazine ® 62 Exemestane 62 TYGACIL 62 Rasagiline 62 odanacatib 62 metaglidasen 62 Silodosin 62 FTY# 62 Vfend 61 Vectibix monotherapy 61 PHX# 61 dexrazoxane 61 Trabectedin 61 CD# monoclonal antibody 61 unresectable stage 61 edifoligide 61 Apoptone 61 R lenalidomide 61 Actimmune R 61 OXi# 61 BioSTAR R 61 imatinib Gleevec ® 61 Pimavanserin 61 BCG refractory 61 EOquin 61 iclaprim 61 ZD# [001] 61 CEQ# 61 OLEPTRO TM 61 elinogrel 61 incyclinide 61 Angiox R 61 Chrysalin 61 confirmatory Phase III 61 ruboxistaurin 61 natalizumab 61 rALLy clinical trial 61 APPRAISE 61 Icatibant 61 stage IIIB 61 lintuzumab 61 Excellarate TM 61 OncoVEX GM CSF 61 FOLFOX4 61 Interferon beta 1b 61 HRPC 61 FRDA 61 Imprime PGG 61 lenalidomide Revlimid R 61 delay bone metastases 61 CCX# 61 mitoxantrone plus 61 Eribulin 61 prostate cancer CRPC 61 Teriparatide 61 carboplatin paclitaxel 61 Altastaph 61 INTEGRILIN ® 61 Santhera 61 Betaferon R 61 malignant pleural mesothelioma 61 Cethromycin 61 Tasimelteon 61 LEUKINE 61 Vaprisol 61 dabigatran etexilate 61 Orencia abatacept 61 perampanel 61 ATL/TV# 61 SHPT 61 Thrombin 61 Preotact 61 Firazyr 61 A1PI 61 alkylating agent 61 aprepitant 61 Behcet uveitis 61 MitraClip device 61 thrombopoietin 61 FIRMAGON 61 investigational therapies 61 Ecallantide 61 nonmelanoma skin cancers 61 Dacogen 61 cangrelor 61 clofarabine 61 drug ISA# 61 liposomal formulation 61 Celebrex celecoxib 61 Pyridorin 61 IAP inhibitor 61 IFN alfa 61 GVAX 61 AnGes 61 alemtuzumab Campath 61 Rescula 61 IMiDs ® compound 61 prucalopride 61 GnRH agonist 61 refractory ovarian cancer 61 GRASPA ® 61 Trastuzumab

Back to home page